EP2178863
Ferli að smíða gagnleg efnasambönd til meðferðar á lifrarbólgu C
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
31.7.2008EP published:
24.10.2012EP application number:
08796910.1
EP translation filed:
21.11.2012Grant published:
15.12.2012EPO information:
European Patent Register
Max expiry date:
30.7.2028Expiry date:
30.7.2020
Title:
PROCESS FOR SYNTHESIZING COMPOUNDS USEFUL FOR TREATING HEPATITIS C
Timeline
Today
31.7.2008EP application
24.10.2012EP Publication
21.11.2012Translation submitted
15.12.2012Registration published
30.7.2020Expires
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Inventor
Name:
PACK, Shawn, K.Address:
New Brunswick, New Jersey, US
Name:
GENG, PengAddress:
New Brunswick, New Jersey, US
Name:
SMITH, Michael, J.Address:
New Brunswick, New Jersey, US
Name:
HAMM, JasonAddress:
New Brunswick, New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
954595 PDate:
8.8.2007Country:
US
Classification
Categories:
C07D 403/14
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 6.6.2013
Expires: 30.7.2014
Payer: Árnason Faktor
Number: 7
Paid: 10.6.2014
Expires: 30.7.2015
Payer: Árnason Faktor
Number: 8
Paid: 9.6.2015
Expires: 30.7.2016
Payer: Árnason Faktor
Number: 9
Paid: 8.6.2016
Expires: 30.7.2017
Payer: Árnason Faktor
Number: 10
Paid: 7.6.2017
Expires: 30.7.2018
Payer: Árnason Faktor
Number: 11
Paid: 7.6.2018
Expires: 30.7.2019
Payer: Árnason Faktor
Number: 12
Paid: 5.6.2019
Expires: 30.7.2020
Payer: Árnason Faktor